Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. pharmaceutical production
Show results for
Products
Services
Software
Training
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Pharmaceutical Production Articles & Analysis: Older

63 news found

Creative Diagnostics Announces Advanced Microbial Genome Editing Services to Accelerate Bio-research

Creative Diagnostics Announces Advanced Microbial Genome Editing Services to Accelerate Bio-research

As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics has introduced its efficient and precise Microbial Genome Editing services to support researchers in the modification of specific target genes within an organism's genome.Microbial cell factories are a promising mode of production for fuels, chemicals, and ...

ByCreative Diagnostics


Protheragen-ING Offers a Full Range of Nonsteroidal Anti-inflammatory APIs, Including Celecoxib and Crisaborole

Protheragen-ING Offers a Full Range of Nonsteroidal Anti-inflammatory APIs, Including Celecoxib and Crisaborole

With its strict quality control and manufacturing process, the certification further solidifies its position as a reliable partner in pharmaceutical solutions. One of Protheragen-ING’s top products is celecoxib (CAS 169590-42-5). ...

ByProtheragen-ING


Alfa Chemistry Expands Pharmaceutical Product Portfolio: Introducing PROTAC Building Blocks, Nucleosides, Intermediates, and APIs

Alfa Chemistry Expands Pharmaceutical Product Portfolio: Introducing PROTAC Building Blocks, Nucleosides, Intermediates, and APIs

Alfa Chemistry is one of the leading chemical manufacturers and suppliers who has been able to maintain its leadership position in the pharmaceutical sector by offering a broad product portfolio that caters to all aspects of the drug creation process. Always innovative and outstanding, Alfa Chemistry now has an extensive range of products within ...

ByAlfa Chemistry


Protheragen-ING Announces Participation in 26th SAPA-NE Annual Conference   

Protheragen-ING Announces Participation in 26th SAPA-NE Annual Conference  

About SAPA-NE SAPA (Sino-American Pharmaceutical Professionals Association) is one of the most active and largest Chinese-based biopharmaceutical professional organizations in North America, with more than 6,000 members, covering the entire ecosystem of pharmaceutical product development, manufacturing, commercialization, international ...

ByProtheragen-ING


Protheragen-ING Announces Participation in the 2024 CPHI North America Conference

Protheragen-ING Announces Participation in the 2024 CPHI North America Conference

[Philadelphia, May 7-9, 2024] - Protheragen-ING, a pharmaceutical products supplier focused on innovative drug discovery and development, is pleased to announce its participation in the highly anticipated 2024 CPHI North America Conference. ...

ByProtheragen-ING


CD Formulation Offers Accurate and Reliable Impurity Determination for Biopharmaceutical Studies

CD Formulation Offers Accurate and Reliable Impurity Determination for Biopharmaceutical Studies

With the growing demand for safe and effective pharmaceutical products, the need for reliable impurity testing has become increasingly important. ...

ByCD Formulation


Stability Analysis Plays a Crucial Role in Pharmaceutical Formulation, Highlighted by CD Formulation   

Stability Analysis Plays a Crucial Role in Pharmaceutical Formulation, Highlighted by CD Formulation  

CD formulation’s expertise in this area allows them to determine the shelf life of pharmaceutical products under accelerated conditions, thus simulating the effects of time in a shorter period. ...

ByCD Formulation


CD Formulation Introduces Powder Flowability Testing to Maximize Tablet Performance   

CD Formulation Introduces Powder Flowability Testing to Maximize Tablet Performance  

This cutting-edge technology promises to revolutionize tablet manufacturing by ensuring high-quality and consistent tablet production for pharmaceutical companies worldwide. Powder flowability plays a crucial role in the tablet manufacturing process, particularly in the analysis of prescription screening processes. ...

ByCD Formulation


CD Formulation’s Physical Parameter Determination: A Crucial Step in Pharmaceutical Analysis and Testing

CD Formulation’s Physical Parameter Determination: A Crucial Step in Pharmaceutical Analysis and Testing

CD Formulation, a CRO service provider of analysis and testing services, offers a comprehensive range of tests for determining physical parameters in pharmaceutical formulations. These tests play a crucial initial role in ensuring the quality, stability, and efficacy of pharmaceutical products. ...

ByCD Formulation


Expanding Possibilities: CD Formulation Unveils Comprehensive Selection of 90+ Active Pharmaceutical Ingredients

Expanding Possibilities: CD Formulation Unveils Comprehensive Selection of 90+ Active Pharmaceutical Ingredients

Emerging as an excipient supplier and a contract research organization (CRO), CD Formulation has flourished in the pharmaceutical industry. The company recently unveiled its latest collection of over 90 active pharmaceutical ingredients (APIs) to the scientific community. ...

ByCD Formulation


CD Formulation: Advancing Pharmaceutical Analysis and Testing through Biological Determination

CD Formulation: Advancing Pharmaceutical Analysis and Testing through Biological Determination

In the pharmaceutical industry, ensuring product safety and efficacy is paramount. Therefore, rigorous testing and analysis procedures are employed to ensure that pharmaceutical products meet the required standards. CD Formulation is emerging as a trusted partner specializing in biological determinations for ...

ByCD Formulation


CD Formulation Unveils Its Latest Offering: A Comprehensive Line of Pharmaceutical Formulation Characterization Testing Services   

CD Formulation Unveils Its Latest Offering: A Comprehensive Line of Pharmaceutical Formulation Characterization Testing Services  

The need for high-quality pharmaceutical development services has never been more pressing. Therefore, in a swift response to such demand, CD Formulation has recently rolled out its new Pharmaceutical Formulation Characterization Testing (PFCT) services, a move aiming to help ensure that the newly developed pharmaceutical ...

ByCD Formulation


CD Formulation: Pharmaceutical Analysis Brings More Confidence to Drug Development and GMP Manufacturing

CD Formulation: Pharmaceutical Analysis Brings More Confidence to Drug Development and GMP Manufacturing

The samples to be tested and analyzed could be in the form of solids, semi-solids, liquids, or gases. In brief, pharmaceutical analysis involves a series of processes, including identification, determination, quantitation, and purification. ...

ByCD Formulation


TOMI to Attend Three Leading Pharmaceutical Conferences in the First Quarter of 2023

TOMI to Attend Three Leading Pharmaceutical Conferences in the First Quarter of 2023

® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, announces that TOMI will present its SteraMist brand of products at three upcoming International Society for Pharmaceutical Engineering (ISPE) Conferences in the first quarter of 2023: The ISPE Facilities of the Future Conference, to be held in ...

BySteraMist Disinfection


STEMart Introduces API Impurity Identification Services for Medical Devices

STEMart Introduces API Impurity Identification Services for Medical Devices

-based provider of comprehensive services for all stages of medical device development, has recently introduced API Impurity Identification services for clients in the medical device, pharmaceutical product, and consumer product industries using a variety of techniques under standard guidance. ...

BySTEMart


Cingulate Initiates Phase 3 Study of Lead Asset CTx-1301, Designed as a True Entire Active-Day Treatment for ADHD

Cingulate Initiates Phase 3 Study of Lead Asset CTx-1301, Designed as a True Entire Active-Day Treatment for ADHD

(NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, today announced the initiation of the first Phase 3 clinical trial of its lead candidate CTx-1301, a novel, investigational, trimodal, ...

ByCingulate


Cingulate Benzinga All Live Access Appearance Rescheduled for December 16

Cingulate Benzinga All Live Access Appearance Rescheduled for December 16

(NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, today announced that Chairman and CEO Shane J. Schaffer, PharmD, will participate in a live Benzinga All Access event on Friday December 16, ...

ByCingulate


Cingulate to Participate in Benzinga All Live Access Event

Cingulate to Participate in Benzinga All Live Access Event

(NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, today announced that Chairman and CEO Shane J. Schaffer will participate in a live Benzinga All Access event on Friday December 2, 2022, at ...

ByCingulate


Cingulate Completes Fed/Fast Study Assessing Food Effect with CTx-1301, Lead Candidate for Treatment of ADHD

Cingulate Completes Fed/Fast Study Assessing Food Effect with CTx-1301, Lead Candidate for Treatment of ADHD

(NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, today announced the completion of its study assessing the effect of food on absorption of its lead candidate CTx-1301, an investigational ...

ByCingulate


Cingulate Announces Agreement with Societal CDMO and Provides Clinical Update

Cingulate Announces Agreement with Societal CDMO and Provides Clinical Update

(NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, today announced it has executed a Master Services Agreement (MSA) with Societal CDMO, Inc. ...

ByCingulate

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT